NHMRC Ext-Funded Rsch Fellow B
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
- My Research
- Grants and Funding
- Professional Activities
Type 2 diabetes is a disease of abnormal systemic metabolism, and yet the most common cause of death is cardiovascular disease. Cher-Rin's current research aims to decipher the molecular mechanism of metabolic and cardiovascular dysfunction, with the ultimate aim of using this information to develop targeted therapeutics.
She has 2 key research questions (and projects):
1. To investigate the interactions between DNA damage and diabetic heart
2. To investigate the impact of altered substrate/fuel selection to the diabetic heart, with particular focus on the ketone bodies
Currently, she and her colleagues are looking for enthusiastic, curious and motivated students to join the lab. For further information about the research and potential project, please send her an email at firstname.lastname@example.org
- Cardiac metabolism, pharmacology & physiology
- Diabetes and diabetic heart
- Takotsubo (stress) syndrome
- Evidence-based medicine
Cher-Rin has >10 years experience as clinical pharmacist, having worked at both tertiary hospital as well as community pharmacy in Australia. As an academic pharmacist, her broad areas of research interests encompass pharmacology, molecular cardiology and metabolism. She undertook her Ph.D. training at University of Adelaide, under the supervision of Prof John Horowitz and with support from the Australian Government National Health & Medical Research Council (NHMRC). Her doctoral thesis focuses on the pharmacological manipulation of cardiac metabolism (using perhexiline, its enantiomers and antiarrhythmics include amiodarone and dronedarone), and the effects on patients with Type 2 diabetes. During which time, she also performed investigations into the pathophysiology of Takotsubo (stress) syndrome and evaluated the interactions between insulin and nitric oxide signaling.
In 2016, Cher-Rin was awarded the Nuffield Medical Fellowship which allowed her to join the Department of Physiology, Anatomy & Genetics at University of Oxford (UK). Here, she was mentored by Professors Kieran Clarke and Rhys Evans. She worked on a number of projects, with particular focus on the investigations of the impact of ketone bodies on diabetes and the diabetic heart.
In late 2019, with support from NHMRC and National Heart Foundation of Australia, Cher-Rin returns to Adelaide to continue her research. Currently she is a member of the editorial board for Cardiovascular drugs and therapy, and holds leadership position at a number of professional organizations.
Date Position Institution name 2019 - ongoing Postdoctoral Fellow University of Adelaide 2016 - 2019 Oxford Nuffield Medical Fellow University of Oxford 2008 - 2016 Rotating pharmacist, Pharmacist registrar, Senior pharmacist The Queen Elizabeth Hospital, SA Department of Health 2007 - 2007 Intern pharmacist Community pharmacies
Language Competency Chinese (Cantonese) Can read, write, speak and peer review Chinese (Mandarin) Can read, write, speak and peer review English Can read, write, speak and peer review Malay Can read, write and speak
Date Institution name Country Title 2017 University of Adelaide Australia Ph.D. 2006 University of South Australia Australia Bachelor of Pharmacy
Year Citation 2015 Chong, C. -R., Stansbourough, J., Raman, B., Nguyen, T. H., Neil, C. J., & Horowitz, J. D. (2015). Determinants of shock and mortality in Takotsubo cardiomyopathy: a cohort study. In EUROPEAN HEART JOURNAL Vol. 36 (pp. 1177-1178). London, ENGLAND: OXFORD UNIV PRESS.
2020 - 2022 C-R Chong, JD Horowitz, YY Chirkov. Project grant, Diabetes SA.
2019 - 2023 C-R Chong. Postdoctoral Fellowship, National Heart Foundation of Australia (co-funded with NHMRC) (ID: 102126)
2019 - 2023 C-R Chong. Peter Doherty Fellowship, National Health and Medical Research Council of Australia (NHMRC) (APP1162356).
2019 - 2020 C-R Chong. Early Career Fellowship, The Hospital Research Foundation (Awarded but did not accept due to acceptance of other fellowships)
2018 - 2019 C-R Chong, KN Timm. Pump priming grant, Oxford British Heart Foundation Centre of Research Excellence (RE/13/1/30181).
2016 - 2019 C-R Chong. Nuffield Medical Fellowship, Nuffield Dominions Trust Fund, University of Oxford.
2014 - 2016 C-R Chong. Dora Lush Biomedical Research Postgraduate Scholarship, NHMRC (APP1075767).
2014 C-R Chong. Affiliate Clinical Development Award, Cardiac Society of Australia and New Zealand (CSANZ)
2013, 2014 C-R Chong. Travelling fellowship, CSANZ.
2013 C-R Chong. Professional development grant, Young Professional Group, SA Department of Health
2011 - 13 C-R Chong. Student travel grant. Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists
2005 C-R Chong Student Vacation Scholarship, The Cancer Council Australia
2005 C-R Chong Student Vacation Scholarship, Royal Adelaide Hospital Research Foundation (awarded but did not accept)
Cher-Rin is involved in the supervision of research placements for third year biomedical students.
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2022 Principal Supervisor Investigating cardiovascular complications of diabetes Doctor of Philosophy Doctorate Full Time Mr Getandale Zeleke Negera
Other Supervision Activities
Date Role Research Topic Location Program Supervision Type Student Load Student Name 2020 - ongoing Principal Supervisor Novel treatment to prevent cardiovascular disease in Type 2 diabetes The University of Adelaide Honours Emily Kovacev
Date Role Committee Institution Country 2021 - ongoing Member Emerging Leaders Committee Australian Cardiovascular Alliance Australia 2020 - ongoing Member Management Committee Basil Hetzel Institute for Translational Health Research Australia 2020 - 2020 Member Bliss Adelaide Bliss Australia
Date Role Editorial Board Name Institution Country 2020 - ongoing Member Cardiovascular Drugs and Therapy - United States
Connect With Me